​Study Status Reporting for Sponsors/CROs
Six (6) to eight (8) weeks prior to the expiration date of a study's approval period, the Sponsor/CRO, as appropriate, must submit a completed 
Protocol Continuing Review Form and any supporting documentation to Schulman as directed on the form. This information is required in order for the Board to conduct continuing review of the protocol.
If you are submitting a site-related Study Status Report on behalf of the site, please reference Study Status Reporting for Sites.